Viewing Study NCT03639194


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-03-01 @ 10:04 AM
Study NCT ID: NCT03639194
Status: COMPLETED
Last Update Posted: 2024-02-09
First Post: 2018-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module